Accumulation of α-oxoaldehydes during oxidative stress: a role in cytotoxicity

Biochemical Pharmacology

Volumn 58, Issue 4, 1999, Pages 641-648

  Abordo, Evelyn A ^a   Minhas, Harjit S ^a   Thornalley, Paul J ^a  

^a UNIVERSITY OF ESSEX   (United Kingdom)

Author keywords

3 Deoxyglucosone; Glutathione; Glyoxal; Glyoxalase; Methylglyoxal; Oxidative stress

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ALDEHYDE DERIVATIVE; AMINOGUANIDINE; DEOXYGLUCOSE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLYOXAL; GLYOXALASE; HYDROGEN PEROXIDE; METHYLGLYOXAL; N(G) NITROARGININE;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DETOXIFICATION; MACROPHAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; CELL LINE; CELL SURVIVAL; DEOXYGLUCOSE; DINITROCHLOROBENZENE; GLUTATHIONE; GLYOXAL; GUANIDINES; HYDROGEN PEROXIDE; MACROPHAGES; MICE; NECROSIS; NITROARGININE; OXIDATIVE STRESS; PYRUVALDEHYDE;

EID: 0033567419     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00132-X     Document Type: Article

References (48)

1. Wells-Knecht K.J., Zyzak D.V., Litchfield J.E., Thorpe S.R., Baynes J.W. Mechanism of autoxidative glycosylation Identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose . J Am Chem Soc. 34:1995;3702-3709.
2. Namiki M., Hayashi T. A new mechanism of the Maillard reaction involving sugar fragmentation and free radical formation. ACS Symp Ser. 215:1983;21-46.
3. Mlakar A., Spiteller G. Previously unknown aldehydic lipid peroxidation compounds of arachidonic acid. Chem Phys Lipids. 79:1996;47-53.
4. Thornalley P.J. Glutathione-dependent detoxification of α-oxoaldehydes by the glyoxalase system Involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors . Chem-Biol Interact. 111-112:1998;137-151.
5. Zyzak D.V., Richardson J.M., Thorpe S.R., Baynes J.W. Formation of reactive intermediates from Amadori compounds under physiological conditions. Arch Biochem Biophys. 316:1995;547-554.
6. Szwergold B.S., Kappler F., Brown T.R. Identification of fructose-3-phosphate in the lens of diabetic rats. Science. 247:1990;451-454.
7. 1 growth arrest and induction of apoptosis . Leuk Res. 20:1996;397-405.
8. Shinoda T., Hayase F., Kato H. Suppression of cell-cycle progression during the S phase of rat fibroblasts by 3-deoxyglucosone, a Maillard reaction intermediate. Biosci Biotech Biochem. 58:1994;2215-2219.
9. Thornalley P.J., Edwards L.G., Kang Y., Wyatt C., Davies N., Ladan M.J., Double J. Antitumour activity of S-p-bromobenzylglutathione cyclopentyl diester in vitro and in vivo. Inhibition of glyoxalase I and induction of apoptosis. Biochem Pharmacol. 51:1996;1365-1372.
10. 2-alkylguanines. Biochemistry. 8:1969;238-245.
11. 32P-postlabelling technique for the analysis of 2′-deoxyguanosine-3′-monophosphate and DNA of methylglyoxal. Carcinogenesis. 15:1994;1887-1894.
12. 2-(1-carboxyethyl)guanine (CEG) as a guanine advanced glycosylation endproduct. Biochemistry. 34:1995;648-655.
13. Hou S.-M., Nori P., Fang J.-L., Vaca C.E. Methylglyoxal induces HPRT mutation and DNA-adducts in human T-lymphocytes in vitro. Environ Mol Mutagen. 26:1995;286-291.
14. Okado A., Kawasaki Y., Hasuike Y., Takahashi M., Teshima T., Fujii J., Taniguchi N. Induction of apoptotic cell death by methylglyoxal and 3-deoxyglucosone in macrophage-derived cell lines. Biochem Biophys Res Commun. 225:1996;219-224.
15. Brinkmann Frye E., Degenhardt T.P., Thorpe S.R., Baynes J.W. Role of the Maillard reaction in aging of tissue proteins. J Biol Chem. 273:1998;18714-18719.
16. Westwood M.E., Argirov O.K., Abordo E.A., Thornalley P.J. Methylglyoxal-modified arginine residues - a signal for receptor-mediated endocytosis and degradation of proteins by monocytic THP-1 cells. Biochem Biophys Acta. 1356:1997;84-94.
17. Thornalley P.J. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Biol. 44:1998;1013-1023.
18. Shan X., Aw T.Y., Jones D.P. Glutathione-dependent protection against oxidative injury. Pharmacol Ther. 47:1990;61-71.
19. 1 macrophages in vitro. J Biochem Toxicol. 10:1996;245-250.
20. Takahashi M., Fujii J., Teshima T., Suzuki K., Shiba T., Taniguchi N. Identity of a major 3-deoxyglucosone-reducing enzyme with aldehyde reductase in rat liver established by amino acid sequencing and cDNA expression. Gene. 127:1993;249-253.
21. Feather M.S., Flynn T.G., Munro K.A., Kubiseski T.J., Walton D.J. Catalysis of reduction of carbohydrate 2-oxoaldehydes (osones) by mammalian aldose reductase and aldehyde reductase. Biochim Biophys Acta. 1244:1995;10-16.
22. Kato H., Van Chuyen N., Shinoda T., Sekiya F., Hayase F. Metabolism of 3-deoxyglucosone, an intermediate compound in the Maillard reaction, administered orally or intravenously to rats. Biochim Biophys Acta. 1035:1990;71-76.
23. Jellum E. Metabolism of the ketoaldehyde α-keto-3-deoxyglucose. Biochim Biophys Acta. 165:1968;357-363.
24. Koren H.S., Handwerger B.S., Wunderlich J.R. Identification of macrophage-like characteristics in a cultured murine tumor line. J Immunol. 114:1975;894-897.
25. Schraufstatter I.U., Hinshaw D.B., Hyslop P.A., Spragg R.G., Cochrane C.G. Glutathione cycle activity and pyridine nucleotide levels in oxidant-induced injury of cells. J Clin Invest. 76:1985;1131-1139.
26. Baker M.A., Cerniglia G.J., Zaman A. Micro plate assay for the measurement of glutathione and glutathione disulfide in large numbers of samples. Anal Biochem. 190:1990;360-365.
27. Shinohara M., Thornalley P.J., Giardino I., Beisswenger P.J., Thorpe S.R., Onorato J., Brownlee M. Overexpression of glyoxalase I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycaemia-induced increases in macromolecular endocytosis. J Clin Invest. 101:1998;1142-1147.
28. α-acetyl-lysine, and bovine serum albumin. J Biol Chem. 269:1994;32299-32305.
29. McLellan A.C., Phillips S.A., Thornalley P.J. The assay of methylglyoxal in biological systems by derivatization with 1,2-diamino-4,5-dimethoxybenzene. Anal Biochem. 206:1992;17-23.
30. Thornalley P.J. Modification of the glyoxalase system in human red blood cells by glucose in vitro. Biochem J. 254:1988;751-755.
31. Westwood ME and Thornalley PJ, Glycation and advanced glycation endproducts. In: The Glycation Hypothesis of Atherosclerosis (Ed. Colaco CALS.), pp. 57-88. Landes Bioscience, Georgetown, Texas, 1997.
32. Weenen H., Tjan S.B. Analysis, structure, and reactivity of 3-deoxyglucosone. ACS Symp Ser. 490:1992;217-231.
33. Vuorinen T. Cleavage of D-arabino-hexos-2-ulose and glyoxal with hydrogen peroxide. Carbohydr Res. 127:1984;319-325.
34. Yoshizumi M., Kourembanas S., Temizer D.H., Cambria R.P., Quertermous T., Lee M.E. Tumour necrosis factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular-endothelial cells. J Biol Chem. 267:1992;9467-9469.
35. Hyslop P.A., Hinshaw D.B., Halsey W.A., Shraufstatter I.U. Mechanisms of oxidant-mediated cell injury. The glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J Biol Chem. 263:1988;1665-1675.
36. Schraufstatter I.U., Hinshaw D.B., Hyslop P.A., Spragg R.G., Cochrane C.G. Oxidant injury of cells. J Clin Invest. 77:1986;1312-1320.
37. Hinshaw D.B., Armstrong B.C., Burger J.M., Beals T.F., Hyslop P.A. ATP and microfilaments in cellular oxidant injury. Am J Pathol. 132:1988;479-488.
38. Mira M.L., Martinho F., Azevedo M.S., Manso C. Oxidative inhibition of red blood cell ATPases by glyceraldehyde. Biochim Biophys Acta. 1060:1998;257-261.
39. Lo T.W.C., Selwood T., Thornalley P.J. Reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins. Biochem Pharmacol. 48:1994;1865-1870.
40. Hirsch J., Petrakova E., Feather M.S. The reaction of some dicarbonyl sugars with aminoguanidine. Carbohydr Res. 232:1992;125-130.
41. Misko T.P., Moore W.M., Kasten T.P., Nickols G.A., Corbett J.A., Tilton R.G., McDaniel M.L., Williamson J.R., Currie M.G. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol. 233:1993;119-125.
42. Giardino I., Fard A.K., Hatchell D.L., Brownlee M. Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis. Diabetes. 47:1998;1114-1120.
43. Al-Abed Y., Bucala R. Efficient scavenging of fatty acid oxidation products by aminoguanidine. Chem Res Toxicol. 10:1997;875-879.
44. Ou P., Wolff S.P. Aminoguanidine A drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro . Biochem Pharmacol. 46:1993;1139-1144.
45. Messina J.P., Lawrence D.A. Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase. J Immunol. 143:1989;1974-1981.
46. 2+ sequestration by the plasma membrane fraction in rat liver. FEBS Lett. 163:1996;136-139.
47. Donnini D., Zambito A.M., Perrella G., Amesi-Impiombato F.S., Curcio F. Glucose may induce cell death through a free radical-mediated mechanism. Biochem Biophys Res Commun. 219:1996;412-417.
48. Thornalley P.J. Advanced glycation and the development of diabetic complications. Unifying the involvement of glucose, methylglyoxal and oxidative stress. Endocrinol Metab. 3:1996;149-166.